Bronchodilatory and Anti-Inflammatory Effects of ASM-024, a Nicotinic Receptor Ligand, Developed for the Treatment of Asthma

Conventional asthma and COPD treatments include the use of bronchodilators, mainly β2-adrenergic agonists, muscarinic receptor antagonists and corticosteroids or leukotriene antagonists as anti-inflammatory agents. These active drugs are administered either separately or given as a fixed-dose combin...

Descripción completa

Detalles Bibliográficos
Autores principales: Assayag, Evelyne Israël, Beaulieu, Marie-Josée, Cormier, Yvon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899211/
https://www.ncbi.nlm.nih.gov/pubmed/24465890
http://dx.doi.org/10.1371/journal.pone.0086091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899211/
https://www.ncbi.nlm.nih.gov/pubmed/24465890
http://dx.doi.org/10.1371/journal.pone.0086091

Ejemplares similares